New triple inhaler could help teens with Hard-to-Control asthma

NCT ID NCT05757102

Recruiting now Disease control Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 17, 2026 · Updated 3 times

Summary

This study tests whether a triple-combination inhaler (containing three drugs) works better than a standard dual-combination inhaler for teenagers aged 12-17 whose asthma is not well controlled. About 292 participants will use either the triple or dual inhaler daily for 24 weeks. The main goal is to see if the triple inhaler improves lung function more than the dual one.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Fluticasone furoate, umeclidinium, and vilanterol (a triple-combination inhaler)
What this could lead to: If it works, this could offer a more effective daily inhaler option for teenagers whose asthma is not well controlled with current two-drug inhalers.
What could go wrong: This is a relatively small, short-term study (24 weeks) in a specific age group. The triple inhaler may not prove significantly better than the standard dual inhaler, and long-term safety in teens is not yet established.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA

Contacts and locations

Locations

GSK Investigational Site
RECRUITING

Birmingham, Alabama, 35244, United States
GSK Investigational Site
RECRUITING

Mobile, Alabama, 36608, United States
GSK Investigational Site
RECRUITING

Paradise Valley, Arizona, 85253, United States
GSK Investigational Site
RECRUITING

Bakersfield, California, 93301, United States
GSK Investigational Site
RECRUITING

Mission Viejo, California, 92691, United States
GSK Investigational Site
COMPLETED

Rolling Hills Estates, California, 90274, United States
GSK Investigational Site
RECRUITING

Colorado Springs, Colorado, 80909, United States
GSK Investigational Site
COMPLETED

Aventura, Florida, 33180, United States
GSK Investigational Site
RECRUITING

Miami, Florida, 33165, United States
GSK Investigational Site
COMPLETED

Miami, Florida, 33173, United States
GSK Investigational Site
RECRUITING

Miami, Florida, 33174, United States
GSK Investigational Site
COMPLETED

Savannah, Georgia, 31406, United States
GSK Investigational Site
RECRUITING

Normal, Illinois, 61761, United States
GSK Investigational Site
RECRUITING

Owensboro, Kentucky, 42301, United States
GSK Investigational Site
COMPLETED

Columbia, Missouri, 65203, United States
GSK Investigational Site
RECRUITING

Missoula, Montana, 59808, United States
GSK Investigational Site
RECRUITING

The Bronx, New York, 10461, United States
GSK Investigational Site
RECRUITING

Cincinnati, Ohio, 45229, United States
GSK Investigational Site
RECRUITING

Cleveland, Ohio, 44106, United States
GSK Investigational Site
COMPLETED

Dayton, Ohio, 45404, United States
GSK Investigational Site
RECRUITING

Oklahoma City, Oklahoma, 73120, United States
GSK Investigational Site
RECRUITING

Charleston, South Carolina, 29420, United States
GSK Investigational Site
RECRUITING

Dallas, Texas, 75225-6301, United States
GSK Investigational Site
RECRUITING

Kerrville, Texas, 78028, United States
GSK Investigational Site
COMPLETED

Plano, Texas, 75034, United States
GSK Investigational Site
COMPLETED

Waco, Texas, 76712, United States
GSK Investigational Site
RECRUITING

Buenos Aires, 1122, Argentina
GSK Investigational Site
RECRUITING

Buenos Aires, 1888, Argentina
GSK Investigational Site
RECRUITING

Buenos Aires, C1023AAB, Argentina
GSK Investigational Site
RECRUITING

Buenos Aires, C1202, Argentina
GSK Investigational Site
RECRUITING

Buenos Aires, C1425BEN, Argentina
GSK Investigational Site
RECRUITING

Córdoba, X5000DCE, Argentina
GSK Investigational Site
RECRUITING

Lanus, B1824KAJ, Argentina
GSK Investigational Site
RECRUITING

Lobos, 7240, Argentina
GSK Investigational Site
RECRUITING

Lujan de Cuyo, 5509, Argentina
GSK Investigational Site
RECRUITING

Mar del Plata, 7600, Argentina
GSK Investigational Site
RECRUITING

Rosario, 2000, Argentina
GSK Investigational Site
RECRUITING

Rosario Provincia de Santa FE, 2000, Argentina
GSK Investigational Site
RECRUITING

San Miguel de Tucumán, T4000IHE, Argentina
GSK Investigational Site
RECRUITING

Santa Fe, 3000, Argentina
GSK Investigational Site
RECRUITING

South Brisbane, Queensland, 4101, Australia
GSK Investigational Site
RECRUITING

North Adelaide, South Australia, 5006, Australia
GSK Investigational Site
RECRUITING

Joondalup WA, Western Australia, 6027, Australia
GSK Investigational Site
RECRUITING

Lo Barnechea, 7691236, Chile
GSK Investigational Site
RECRUITING

Santiago, 7630000, Chile
GSK Investigational Site
RECRUITING

Santiago, 8320000, Chile
GSK Investigational Site
RECRUITING

Ashkelon, 7830604, Israel
GSK Investigational Site
RECRUITING

Haifa, 3109600, Israel
GSK Investigational Site
RECRUITING

Haifa, 3436212, Israel
GSK Investigational Site
RECRUITING

Petah Tikva, 49202, Israel
GSK Investigational Site
RECRUITING

Guadalajara, 44100, Mexico
GSK Investigational Site
RECRUITING

Monterrey, 64460, Mexico
GSK Investigational Site
RECRUITING

San Juan del Río, 76800, Mexico
GSK Investigational Site
RECRUITING

Ebdentown, Upper Hutt, 5018, New Zealand
GSK Investigational Site
RECRUITING

Cheongju Chungcheongbuk-do, 28644, South Korea
GSK Investigational Site
COMPLETED

Seoul, 03722, South Korea
GSK Investigational Site
RECRUITING

Seoul, 05505, South Korea
GSK Investigational Site
RECRUITING

Seoul, 2447, South Korea
GSK Investigational Site
RECRUITING

Adana, 1173, Turkey (Türkiye)
GSK Investigational Site
RECRUITING

Antalya, 07070, Turkey (Türkiye)
GSK Investigational Site
RECRUITING

Istanbul, 34010, Turkey (Türkiye)
GSK Investigational Site
RECRUITING

Istanbul, 34899, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.